Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5701–5750 of 18416
Frances Scally, who had served as the Company’s Interim Chief Financial Officer pursuant to such agreements with DLA, ceased serving as an officer of the Company.
the Board of Directors of the Company (the “Board”) has designated Neil Dey, the Company’s President and Chief Executive Officer, as the Company’s the principal financial and accounting officer, in addition to serving as principal executive officer.
appointed Brendon Fischer as the Company’s interim Chief Financial Officer (“CFO”), effective April 2, 2024.
On March 27, 2024, Paul J. Casey, Chief, Chief Executive Officer of the Company, notified the Company of his intention to retire as Chief Executive Officer of the Company effective March 29, 2024.
Effective March 29, 2024, the Board appointed Mr. Aaron Green, to serve as Chief Executive Officer of the Company to fill the vacancy created by the retirement of Paul Casey.
Carl A. Grimstad, the chief executive officer, Armen Yeghyazarians, the chief financial officer and chief accounting officer, Thomas C. Pritchard, general counsel, David Cronin, chief engagement officer, and Timothy Newton, chief technology officer were terminated as executive officers of the Company.
Carl A. Grimstad, the chief executive officer, Armen Yeghyazarians, the chief financial officer and chief accounting officer, Thomas C. Pritchard, general counsel, David Cronin, chief engagement officer, and Timothy Newton, chief technology officer were terminated as executive officers of the Company.
On March 26, 2024, the Company appointed Robert E. Wahlman as Chief Financial Officer and Executive Vice President of both the Company and the Bank.
On March 26, 2024, Javvis Jacobson ceased to serve as Chief Financial Officer and Executive Vice President of both the Company and the Bank but will continue to serve as Treasurer of the Bank.
In connection with Mr. Kyle’s notification, the Company has reached an agreement with Tarak Mehta to become the President and Chief Executive Officer of the Company on September 5, 2024 following the conclusion of a negotiated transition period with his current employer (the “Appointment Date”).
On March 26, 2024, Richard G. Kyle, President and Chief Executive Officer of The Timken Company (the “Company”) and member of the Company’s Board of Directors (the “Board”), notified the Company of his intention to retire from his position as President and Chief Executive Officer.
On March 29, 2024, Dynavax Technologies Corporation (the “Company”) appointed Ryan Spencer to serve in a temporary capacity as Interim Chief Financial Officer (principal financial officer) of the Company while Kelly MacDonald is on maternity leave, commencing April 1, 2024.
American National and American National Bank and Trust Company (“AMNB Bank”) entered into a separation agreement with Jeffrey Haley, President and Chief Executive Officer of American National, which provided for termination of Mr. Haley’s employment with American National and American National Bank at the Effective Time
On March 22, 2024, GCT announced that the Board of Directors of GCT had appointed Edmond Cheng as Chief Financial Officer (CFO) effective March 18, 2024.
On April 1, 2024, the Company announced its appointment of Peter Sorensen as its new Chief Financial Officer and designated him the principal financial officer of the Company, effective on the same date.
On March 28, 2024, Sanuwave Health, Inc. (the “Company”) terminated without cause its chief financial officer, Toni Rinow, effective immediately.
On April 1, 2024, Jacobs Solutions Inc. (the “Company”) announced the departure of Claudia Jaramillo, Executive Vice President, Chief Financial Officer, effective April 15, 2024 (the “Effective Date”).
The Company also announced that Kevin Berryman, age 65, currently Special Advisor to the Company’s Chief Executive Officer, has succeeded Ms. Jaramillo as the Company’s interim Chief Financial Officer, effective as of March 29, 2024.
the Company’s board of directors (the “Board”) appointed Mr. Kenneth Galbraith, the Company’s current Chair of the Board, President and Chief Executive Officer, as the Company’s interim Chief Financial Officer.
On March 31, 2024, Zymeworks Inc. (the “Company”) removed Dr. Christopher Astle from the positions of Senior Vice President and Chief Financial Officer, including as the Company’s principal financial officer and principal accounting officer, effective immediately.
Following Mr. Bagshaw’s retirement, on April 1, 2024, John T.C. Lee, President and Chief Executive Officer of the Company, assumed the role of principal financial officer of the Company on an interim basis while the Company continues its search for Mr. Bagshaw’s successor.
As previously announced, on April 1, 2024, Seth H. Bagshaw retired as Executive Vice President, Chief Financial Officer and Treasurer of MKS Instruments, Inc. (the “Company”).
Concurrently, the Company and Mr. Asija entered into a first amendment (the “Asija Amendment”) to the Asija Agreement to modify the effective date on which Mr. Asija will assume the role as the Company’s Chief Financial Officer, from April 1, 2024 to April 6, 2024.
the Company previously announced on February 7, 2024 the mutual agreement with James Dullinger, the Company’s current Chief Financial Officer, to not renew Mr. Dullinger’s existing Employment Agreement
On March 28, 2024, Veeva Systems Inc. (“Veeva” or the “Company”) and Brent Bowman established, via mutual agreement, that Mr. Bowman’s tenure as Chief Financial Officer (“CFO”) and Principal Financial Officer (“PFO”) will end as of the close of business on April 1, 2024
Tim Cabral, the Company’s CFO from 2010 to 2020 and a current member of Veeva’s board of directors, will serve as Interim CFO and PFO until a replacement is named.
both Dr. Joanne M. Hackett and Dr. Jean-Christophe Renondin resigned from AgeX’s board of directors and all respective committee membership of AgeX’s board of directors, effective as of the effective time of the Merger and (ii) Dr. Hackett was terminated as interim CEO of the Company effective as of the effective time of the Merger.
the decision of the Board to place Brendon B. Falconer, Senior Executive Vice President and Chief Financial Officer of the Company, on leave effective April 1, 2024
Effective April 1, 2024, the Board of Directors (the “Board”) of Old National Bancorp (the “Company”) appointed John V. Moran, IV as Interim Chief Financial Officer
the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary
Jin-Goon Kim ("Mr. Kim"), the Company’s current Chairman and Chief Executive Officer, will serve as the Company’s interim CFO and will assume the roles of principal financial officer and principal accounting officer.
received a notice from Steven Norman ("Mr. Norman"), who served as a director and the Chief Financial Officer (the "CFO") of the Company, of his decision to resign as the CFO of the Company and as a member of the Board and all committees thereof, effective immediately.
On March 27, 2024, Lisa M. Vorakoun, age 40, was appointed Interim Chief Financial Officer and Treasurer of CTO Realty Growth, Inc. (the “Company”), effective April 1, 2024
On March 27, 2024, Lisa M. Vorakoun, age 40, was appointed Interim Chief Financial Officer and Treasurer of Alpine Income Property Trust, Inc. (the “Company”), effective April 1, 2024
On March 25, 2024, Matthew Preston, Chief Financial Officer of Intrepid Potash, Inc. (the “Company”), informed the Company that he will be leaving his position to pursue another business opportunity, effective April 12, 2024.
On March 25, 2024, Aaron Ondrey was appointed by Rocket Pharmaceuticals, Inc. (the “Company”) as the Company’s Chief Financial Officer and Principal Financial Officer.
In connection with Mr. Schierhorn's resignation, Michael G. Huston, age 56, will be appointed to the position of President, Chief Executive Officer and Chief Operating Officer of the Company and President and Chief Executive Officer of the Bank, effective April 6, 2024.
On March 29, 2024, Northrim BanCorp, Inc. (the “Company”) and Northrim Bank (the “Bank”) announced by press release that Mr. Joseph M. Schierhorn intends to resign from his position as President, Chief Executive Officer and Chief Operating Officer of the Company and Chief Executive Officer of the Bank, effective April 6, 2024.
the Board of Directors of the Company appointed Charles Garner to serve as the Company’s principal financial officer and principal accounting officer, effective as of March 25, 2024.
On March 25, 2024, Susan L. Drexler, Interim Chief Financial Officer, principal financial officer and principal accounting officer of Aileron Therapeutics, Inc. (the “Company”), notified the Company of her resignation, effective as of March 25, 2024.
Separately, the Company and Mr. Garner have agreed that his employment with the Company will end effective as of May 15, 2024.
On March 29, 2024, Stacy McLaughlin resigned as Chief Financial Officer of Splash Beverage Group, Inc. (the “Company”).
On March 28, 2024, the Boards of Directors of Provident Bancorp, Inc. (the “Company”) and its wholly owned subsidiary, BankProv (the “Bank”), appointed Kenneth R. Fisher Acting Chief Financial Officer.
Matt DeSoto became the sole director, president and chief executive officer of the Company
On March 24, 2024, the board of directors of ZURA (the “ Board ”) approved a Chief Executive Officer (“ CEO ”) transition from Someit Sidhu, our Founder, CEO and Director, to Robert Lisicki, effective April 8, 2024.
Mr. Lisicki, the Company’s current President and Chief Operating Officer, will be promoted to the Company’s Chief Executive Officer on April 8, 2024.
On March 28, 2024, the Board of Directors (the “Board”) of Hilton Grand Vacations Inc. (the “Company”) approved the promotion and appointment of Daniel J. Mathewes, the Company’s current Senior Executive Vice President and Chief Financial Officer, as the Company’s President and Chief Financial Officer effective as of April 1, 2024.
executed an employment agreement with John DeSimone in connection with his appointment as the Company’s Chief Financial Officer (the “CFO Employment Agreement”), effective March 17, 2024.
On March 27, 2024, the Board of Directors appointed Mr. Tyler Minnick to act as interim Chief Financial Officer of the Company effective April 1, 2024.
Mr. Michael McClelland tendered his resignation as the Chief Financial Officer of the Company effective March 31, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.